770 related articles for article (PubMed ID: 28750927)
1. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of inflammatory response by a novel chalcone protects kidney and heart from hyperglycemia-induced injuries in type 1 diabetic mice.
Fang Q; Wang J; Wang L; Zhang Y; Yin H; Li Y; Tong C; Liang G; Zheng C
Toxicol Appl Pharmacol; 2015 Oct; 288(2):179-91. PubMed ID: 26206226
[TBL] [Abstract][Full Text] [Related]
3. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice.
Chen H; Yang X; Lu K; Lu C; Zhao Y; Zheng S; Li J; Huang Z; Huang Y; Zhang Y; Liang G
Toxicol Lett; 2017 Aug; 278():48-58. PubMed ID: 28700904
[TBL] [Abstract][Full Text] [Related]
5. CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys.
Yang X; Luo W; Li L; Hu X; Xu M; Wang Y; Feng J; Qian J; Guan X; Zhao Y; Liang G
Toxicol Appl Pharmacol; 2021 Apr; 416():115465. PubMed ID: 33631230
[TBL] [Abstract][Full Text] [Related]
6. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
7. Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-κB signaling pathways in C57BL/6 mice.
Li Y; Hou JG; Liu Z; Gong XJ; Hu JN; Wang YP; Liu WC; Lin XH; Wang Z; Li W
J Ethnopharmacol; 2021 Mar; 267():113500. PubMed ID: 33091499
[TBL] [Abstract][Full Text] [Related]
8. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.
Zhang H; Yang Y; Wang Y; Wang B; Li R
Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart.
Pan Y; Zhu G; Wang Y; Cai L; Cai Y; Hu J; Li Y; Yan Y; Wang Z; Li X; Wei T; Liang G
J Nutr Biochem; 2013 Jan; 24(1):146-55. PubMed ID: 22819547
[TBL] [Abstract][Full Text] [Related]
11. Studies on the Antidiabetic and Antinephritic Activities of Paecilomyces hepiali Water Extract in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats.
Wang J; Teng L; Liu Y; Hu W; Chen W; Hu X; Wang Y; Wang D
J Diabetes Res; 2016; 2016():4368380. PubMed ID: 27034961
[TBL] [Abstract][Full Text] [Related]
12. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
Tone A; Shikata K; Sasaki M; Ohga S; Yozai K; Nishishita S; Usui H; Nagase R; Ogawa D; Okada S; Shikata Y; Wada J; Makino H
Diabetologia; 2005 Nov; 48(11):2402-11. PubMed ID: 16231067
[TBL] [Abstract][Full Text] [Related]
13. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
[TBL] [Abstract][Full Text] [Related]
14. Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats.
Barzegar-Fallah A; Alimoradi H; Asadi F; Dehpour AR; Asgari M; Shafiei M
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):361-8. PubMed ID: 25676798
[TBL] [Abstract][Full Text] [Related]
15. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
Gangadharan Komala M; Gross S; Zaky A; Pollock C; Panchapakesan U
Nephrology (Carlton); 2016 May; 21(5):423-31. PubMed ID: 26375854
[TBL] [Abstract][Full Text] [Related]
16. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
[TBL] [Abstract][Full Text] [Related]
17. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways.
Hu X; Zhang X; Jin G; Shi Z; Sun W; Chen F
Fundam Clin Pharmacol; 2017 Feb; 31(1):54-63. PubMed ID: 27521287
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effects of brown adipose tissue activation in diabetic mice.
Cai YY; Zhang HB; Fan CX; Zeng YM; Zou SZ; Wu CY; Wang L; Fang S; Li P; Xue YM; Guan MP
J Diabetes; 2019 Dec; 11(12):958-970. PubMed ID: 31020790
[TBL] [Abstract][Full Text] [Related]
20. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
